Debiopharm Innovation Fund
Corporate VCLausanne · Pre-Seed–Late Stage · 18 people tracked
Find your way into Debiopharm Innovation Fund
1,625 people in our graph share verified history with the Debiopharm Innovation Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
As Debiopharm's corporate venture arm, the fund backs digital health and health tech startups working to transform pharmaceutical R&D and cancer care. Beyond capital, it offers portfolio companies strategic guidance, deepened market knowledge, pharma expertise, and access to Debiopharm's network, positioning itself as a launchpad for scalable, investment-ready companies aiming to improve outcomes for patients globally.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & curated & public directories
What they invest in
from 18 of 19 portfolio companiesAI & Machine Learning ×14Medical Devices ×12Biotech ×11Healthtech ×10Digital Health ×7Data & Infrastructure ×4SaaS ×4Deep Tech ×2
HQs:United States×3Switzerland×2Germany×2France×2United Kingdom×2Belgium×1
Who they back
founder profiles across 7 portfolio companiesWhat their founders studiedfrom 11 founders with field-of-study data
Engineering ×4Business & Management ×2Life Sciences ×2Mathematics & Statistics ×2
Where their founders worked beforefrom 13 founders with career history
Baylor College of Medicine ×2
Investments · 19 tracked
founders shown can be your intro pathBy year:2023 · 42016 · 15 dated
MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.
Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US
Brian Irwin(Chief Executive Officer)inJeffrey Thibeault(Chief Technology Officer)in
Co-investorsNina Capital
Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials.
AI & Machine LearningEnterprise SoftwareMedical Devices
Amit Patel(Founder)inMatt Purri, PhD(Founder)in
Co-investorsEntrepreneurs Roundtable Accelerator (ERA)Remarkable VenturesSurface Ventures
StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights.
AI & Machine LearningBiotechHealthtechMedical DevicesBerlin, DE
Daniel Truhn(Co-Founder & Chief Medical Officer)inFiras Khader(Co-Founder & CTO)inJakob Nikolas Kather(Co-Founder & CSO)inOmar El Nahhas(CEO & Co-founder)in
Co-investorsNeulogy VenturesPICUS CAPITALAlvenHeliad AGHV Capital
Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.
AI & Machine LearningData & InfrastructureFintech
Co-investorsPrimary Venture PartnersGalapagos Capital
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA
Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)
Co-investorsCreative Destruction Lab (CDL)FusionOrbiMedBenchstrength Partners
BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine.
AI & Machine LearningBiotechData & InfrastructureHealthtechZurich, CH
Nino da Silva(Executive Officer)inTero Silvola(Executive Officer, Director)inMukhtar Ahmed(Chief Executive Officer)in
BoardHannu Vaajoensuu(Director)Jari Heikkinen(Director)Erich Platzer(Director)
Co-investorsJolt CapitalStartAngels Network
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Co-investorsAngelini VenturesTaiwania CapitalFirst Star VenturesScaleX Venturesredalpine
Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.
AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR
Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)
Co-investorsM VenturesOmnes Capital
Debiopharm is a biopharmaceutical company that develops and manufactures drugs to treat cancer and infectious diseases, and invests in digital health startups.
BiotechDigital HealthMedical DevicesSwitzerland, CH
Rolland-Yves Mauvernay
BoardThierry Mauvernay
ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development.
AI & Machine LearningBiotechMedical Devices
Ian Levine(Founder)in
Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning.
AI & Machine LearningBiotechData & InfrastructureHealthtechSaaSMartinsried, DE
Tanya Aneichyk(PhD, CEO)in
Co-investorsTechstars
Concr combines AI-driven computational methods with biological expertise to develop precision oncology tools that improve drug selection and delivery for cancer patients.
AI & Machine LearningBiotechMedical DevicesGlasgow, GB
Matthew Griffiths(Chief Technology Officer & Co-Founder)Uzma Asghar(Advisor, Medical Strategy & Co-Founder)Matt Foster(Non-Executive Director (Australia) & Co-Founder)
Co-investorsAvonmore DevelopmentsCambridge Angels groupDeep Science VenturesOncology Ventures
Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation.
AI & Machine LearningDigital HealthMedical DevicesParis, FR
Paul Herent, M.D., Msc(Founder)inPaul Hérent(Co-Founder and CEO)inPierre Manceron(Co-Founder and CSO)inSebastian Schwarz(COO)inDamien Benard(CFO)in
Co-investorsGalion.exeKurma PartnersNewfund CapitalFounders FutureStartX
Stitch is a platform for clinical research sites that provides participants with a digital interface for their study visits, appointment reminders, and feedback, while reducing administrative workload for study coordinators.
Digital HealthHealthtechSaaSLondon, GB
Mike Sterling(Founder)in
Co-investorsBoost Capital PartnersForm VenturesOncology VenturesBenchmarkY Combinator
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Anca Copaescu(Founder)inMark Di Ianni(Executive Officer, Director, Promoter)Paulo Carvalho(Executive Officer)inMark Weinstein(Executive Officer, Director)in
BoardRob Hess(Director)Vincent Lepreux(Director)in
Co-investorsBand of AngelsHearstLabBascom VenturesDecathlon Capital PartnersGolden SeedsOsage Venture Partners+2 more
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data.
CybersecurityData & InfrastructureDeep TechDigital HealthHealthtechBelgium, BE
Co-investorsInflection.xyz14Peaks CapitalFounderful
ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.
AI & Machine LearningBiotechHealthtechMedical Devices
Kenneth To(Chief Executive Officer)inKeith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)inGeorge Hennen(Chief Technology Officer)inRafay Azhar(Medical Director)in
Co-investorsSFU VentureLabsSwan Venture FundWittington VenturesWUTIF Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HopeAI
Portfolio news
latest coverage across their companiesOctozi · techfundingnews.com · Sep 2, 2026
Iktos · techfundingnews.com · Jun 19, 2026
Altis · latamlist.com · Dec 18, 2025
Strategikon Pharma · finance.yahoo.com · Jun 10, 2025
Frequently asked questions
- How many investments has Debiopharm Innovation Fund made?
- Debiopharm Innovation Fund has 19 tracked investments.
- What stage does Debiopharm Innovation Fund invest at?
- Debiopharm Innovation Fund invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What is Debiopharm Innovation Fund's typical check size?
- Debiopharm Innovation Fund typically writes checks of $1M – $5M.
- What sectors does Debiopharm Innovation Fund focus on?
- Debiopharm Innovation Fund focuses on Biotech, Digital Health, Healthtech.
- Where is Debiopharm Innovation Fund located?
- Debiopharm Innovation Fund is headquartered in Lausanne, CH.
- Does Debiopharm Innovation Fund lead rounds?
- Yes, Debiopharm Innovation Fund leads investment rounds.
- Who does Debiopharm Innovation Fund co-invest with?
- Debiopharm Innovation Fund most often shares deals with Oncology Ventures, Newfund Capital, OrbiMed, among 26 tracked co-investors.
Media · Podcasts & interviews
featuring the teamFH23 - An interview with Marc Cikes, Managing Director Debiopharm, and Tom Gibbs, Investment Director Debiopharm Innovation Fund
Marc Cikes · vimeo.com
Debiopharm at AACR: First Clinical Data from the MYTHIC Trial (zedoresertib + lunresertib)
DebiopharmTV
Overcoming ADC Linker Challenges: The MultiLINK™ Technology Suite
DebiopharmTV
ADC Talks - Olivier Cochet
DebiopharmTV
ADC Talks - Sophie and Marianna
DebiopharmTV
Antoine’s Journey Finding Purpose at Debiopharm
DebiopharmTV
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.